BioAge seeks nearly $200 million in initial public offering
September 27, 2024 at 07:06 AM EDT
The company is concentrating its aging diseases focus on weight loss and diabetes control.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |